FindTrial
Sign In

COMPARISON OF ROPIVACAINE (0.5%) AND LEVOBUPIVACAINE (0.5%) IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK IN UPPER LIMB ORTHOPAEDIC SURGERIES

COMPARISON OF ROPIVACAINE (0.5%) AND LEVOBUPIVACAINE (0.5%) IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK IN UPPER LIMB ORTHOPAEDIC SURGERIES â?? A DOUBLE BLIND RANDOMISED CONTROL TRIAL - Not applicable

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054260
Enrollment
94
Registered
2023-06-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S42- Fracture of shoulder and upper arm

Interventions

Intervention1: ROPIVACAINE: Inj. Ropivacaine hydrochloride (0.5%) Dose: 30cc , Route of administration:Supraclavicular brachial plexus block Duration: 1 time intervention Control Intervention1: L

Sponsors

YOGINI KELAWALA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with ASA Grade I,II and III of either gender. All patients undergoing elective and emergency upper limb orthopaedic surgeries. Age group of 18 to 65 years. Patient with body weight upto 80 kg.

Exclusion criteria

Exclusion criteria: Patient having hypersensitivity to the study drugs by taking history.

Design outcomes

Primary

MeasureTime frame
To estimate onset of sensory block in both the groups. To estimate duration of sensory block in both the groups. To estimate onset of motor block in both the groups. To estimate duration of motor block in both the groups. To access time of rescue analgesia in both the groups. Timepoint: AT THE END OF 15 MONTHS—

Secondary

MeasureTime frame
To observe changes in HR,MAP, SpO2 in both the groups. To compare side effects like hypotension, bradycardia, nausea, vomiting in both the groups. Timepoint: AT THE END OF 15 MONTHS—

Countries

India

Contacts

Public ContactYOGINI KELAWALA

GOVERNMENT MEDICAL COLLEGE, BHAVNAGAR

drshilpadoshi@yahoo.in9428810763

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026